Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (di/ S) Regulatory News (SPSC)

Share Price Information for Spectra (di/ S) (SPSC)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
120.00
Ask:
200.00
Spread: 80.00 (66.667%)
Market Cap: £77.39m
SPSC Live PriceLast checked at - London Stock Exchange

Intraday Spectra (di/ S) Share Chart

Share Buyback Programme

25 Nov 2025 07:00

RNS Number : 8151I
Spectra Systems Corporation
25 November 2025
 

Spectra Systems Corporation

(The "Company" or "Spectra Systems")

Share Buyback Programme

Spectra Systems, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software, announces the launch of an initial share buyback programme of unrestricted common shares of US$0.01 each ("Common Shares") to repurchase up to US$350,000 worth of Common Shares (the "Buyback Programme"), effective from today.

The Board considers the Buyback Programme to be in the best interests of all shareholders, given the cash generative nature of the business and the surplus cash the Company holds. It is also consistent with the Board's desire to increase shareholder value/ returns.

The Company has appointed its broker, Zeus Capital Limited ("Zeus"), to manage the Buyback Programme to repurchase Ordinary Shares on its behalf and entered into an irrevocable and non-discretionary arrangement on 24 November 2025 with Zeus, to enable Zeus to conduct the Buyback Programme on a broker-managed basis. Zeus will make trading decisions in relation to the Buyback Programme independently of the Company, within certain defined parameters.

The Buyback Programme commences today and will end on the earlier of the date upon which the aggregate consideration paid for Common Shares reaches US$350,000 or 5 December 2025 (the "Buyback Period"). During the Buyback Period the Company has no power to invoke any changes to the authority and any purchases will be undertaken by Zeus, acting independently of, and uninfluenced by the Company.

Common Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. The Buyback Programme is in accordance with the Company's general authority to purchase its own shares under Delaware General Corporation Law. The price paid for Common Shares under the Buyback Programme will be no more than: a) 105 per cent. of the average trading price of the Ordinary Shares as derived from the middle market quotations for an Ordinary Share on the London Stock Exchange Daily Official List for the five trading days immediately preceding the date on which an Ordinary Share is contracted to be purchased; and b) £1.35.

Under the Buyback Programme, the repurchased shares will be cancelled.

The Buyback Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (each as in force in the UK from time to time, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019.

The Company will make further announcements in due course following any share purchases conducted through the Buyback Programme.

Following this announcement, the issued share capital of the Company remains unchanged at:

· 47,758,431 shares in the unrestricted line ISIN number US84756T1060 (AIM:SPSY); and

· 542,258 shares in the Regulation S stock line ISIN number USU8457D1091 (AIM:SPSC)

Spectra Systems has no Shares in treasury, therefore 48,300,689 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

The Company confirms that it currently has no unpublished price sensitive information.

Enquiries:

 

Spectra Systems Corporation 

Dr. Nabil Lawandy, Chief Executive Officer 

Tel: +1 (0)401 274 4700 

Zeus (Nominated Adviser and Joint Broker)

James Joyce / James Bavister (Investment Banking) 

Fraser Marshall (Corporate Broking) 

 

Allenby Capital Limited (Joint Broker) 

Nick Naylor/James Reeve (Corporate Finance) 

Amrit Nahal (Sales and Corporate Broking)

Tel: +44 (0)20 3829 5000

 

Tel: +44 (0)20 3328 5665 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGBWGUPAPUC
Date   Source Headline
5th Jan 20214:02 pmRNSDirectorate
5th Jan 20217:00 amRNSShare Buy-Back
14th Dec 20207:01 amRNSTwo Lottery Renewals
14th Dec 20207:00 amRNSAcquisition of interest - Solaris BioSciences, Inc
21st Oct 20209:06 amRNSSecond Price Monitoring Extn
21st Oct 20209:01 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSContract with a Central Bank
14th Oct 20205:27 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSRemoval of Regulation S Restrictions
11th Sep 20204:34 pmRNSExercise of Options and Director/PDMR Shareholding
10th Sep 20207:00 amRNSExercise of Options and Director/PDMR Shareholding
7th Sep 20207:00 amRNSInterim Results for the Six Months 30 June 20
25th Aug 20204:11 pmRNSHolding(s) in Company
15th Jul 20206:25 pmRNSDirector Dealings
9th Jul 20207:00 amRNSContract with a Major Central Bank
26th Jun 20207:00 amRNSShare Buy-Back
25th Jun 20207:00 amRNSShare Buy-Back and Removal of Reg S Restrictions
16th Jun 20203:23 pmRNSShare Buy-Back
10th Jun 20207:00 amRNSAsian Central Bank Contract Update
26th May 20207:00 amRNSDirector Dealings
15th May 20205:24 pmRNSExercise of Options and Removal of Regulation S
30th Apr 20208:51 amRNSPosting of Annual Report and Accounts
3rd Apr 20204:56 pmRNSShare Buy-Back and Removal of Reg S Restrictions
23rd Mar 202012:37 pmRNSAudited Results
16th Mar 20201:59 pmRNSHolding(s) in Company
9th Mar 20204:41 pmRNSPrice Monitoring Extension
21st Feb 20207:00 amRNSShare Buy-Back
11th Nov 20193:30 pmRNSHolding(s) in Company
30th Oct 20191:39 pmRNSHolding(s) in Company
16th Oct 20197:00 amRNSHolding(s) in Company
25th Sep 20192:59 pmRNSHolding(s) in Company
24th Sep 20197:00 amRNSInterim Results
17th Sep 20197:00 amRNSFunding Approval - G7 Central Bank
1st Aug 20197:00 amRNSPolymer Banknote Substrate Supply Agreement
15th Jul 20197:00 amRNSNew Lottery Security Contracts
24th Jun 20197:00 amRNSAnnual General Meeting Lack of Quorum
11th Jun 20197:00 amRNSFive Year Optical Materials Supply Contract
29th May 20194:12 pmRNSExercise of Options
29th May 20197:00 amRNSTrading Update
28th May 20197:00 amRNSRemoval of Regulation S restrictions from shares
17th May 20193:21 pmRNSRemoval of Regulation S restrictions from shares
10th May 20192:31 pmRNSPosting of AGM Notice
10th May 20192:15 pmRNSShare Buy-Back
26th Apr 20198:55 amRNSPosting of Annual Report and Accounts
24th Apr 20197:00 amRNSRemoval of Regulation S Restrictions from Stock
18th Apr 20197:00 amRNSExercise of Options and Director/PDMR Shareholding
15th Apr 20197:00 amRNSUpdated CEO Employment Agreement
10th Apr 20197:00 amRNSShare Buy-Back Programme
25th Mar 20197:00 amRNSPreliminary Results
18th Mar 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.